Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

522.81
-3.9200-0.74%
Post-market: 522.810.00000.00%19:58 EDT
Volume:1.15M
Turnover:601.42M
Market Cap:132.65B
PE:30.43
High:529.72
Open:525.26
Low:522.74
Close:526.73
52wk High:560.25
52wk Low:392.50
Shares:253.72M
Float Shares:253.72M
Volume Ratio:1.29
T/O Rate:0.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):17.18
EPS(LYR):15.32
ROE:23.54%
ROA:11.93%
PB:6.55
PE(LYR):34.13

Loading ...

Vertex Pharmaceuticals Incorporated - Inaxaplin Generally Safe and Well Tolerated in Both Amkd Cohorts

THOMSON REUTERS
·
Sep 22

Vertex Announces Positive Results from Phase 2B Amplified Study of Inaxaplin in Additional Populations of People with Apol1-Mediated Kidney Disease (Amkd) and Completion of Enrollment in the Phase 2/3 Amplitude Trial

THOMSON REUTERS
·
Sep 22

Vertex Pharmaceuticals Incorporated : Leerink Partners Resumes Coverage with Outperform Rating; Target Price $594

THOMSON REUTERS
·
Sep 21

Correction to Vertex Material Listing Article on Sept. 17

Dow Jones
·
Sep 21

Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 19

Vertex wins approval for 24/7 underground operations at Reward Gold Mine

TIPRANKS
·
Sep 18

Vortex Energy Moves to Acquire Saskatchewan Meadows Project for Future Energy Storage Potential

TIPRANKS
·
Sep 18

Malaysia's Vertex Material Sets Sights on 2027 U.S. Listing

Dow Jones
·
Sep 17

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND) and Charles River Labs (CRL)

TIPRANKS
·
Sep 16

Vertex Pharmaceuticals partners with Lindsey Vonn for JOURNAVX awareness

TIPRANKS
·
Sep 15

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Centene (CNC), Natera (NTRA) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Sep 15

Vertex Minerals Revises Timeline for Proposed Securities Issue

TIPRANKS
·
Sep 14

Vertex Pharmaceuticals Price Target Raised to $560.00/Share from $515.00 by JP Morgan

Dow Jones
·
Sep 11

Vertex Minerals Confirms Reward Gold Mine Resource After ASX‑Driven Update

TIPRANKS
·
Sep 11

Vertex Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 11

Vertex Pharma EVP Jasper Van Grunsven Files Initial Beneficial Ownership Statement

Reuters
·
Sep 11

Vertex Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.06% on Sep 8: What Signal Does It Send?

TradingKey
·
Sep 09

Movement Alert|Vertex Pharmaceuticals Falls 3.1% in Regular Trading, Trading at $527.91

Market Focus
·
Sep 08

Aclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts

TIPRANKS
·
Sep 05